Also trades as: HOFBF (OTC) · $vol 0M
HBC.OL OSL
Hofseth BioCare ASA
1W: -5.7%
1M: -3.6%
3M: -11.3%
YTD: -1.5%
1Y: -30.0%
3Y: -56.2%
5Y: -82.0%
kr 1.33 ($0.14)
+0.03 (+2.31%)
Weekly Expected Move ±9.1%
kr 1
kr 1
kr 1
kr 1
kr 2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$38M
-293.1% ▼
Capital Expenditures
$25M
-521.4% ▼
5Y CAGR: -14.2%
Free Cash Flow
-$64M
-359.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$41M
+2358.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$126M | -$137M | -$107M | -$125M | -$135M |
| Depreciation & Amort. | $29M | $30M | $36M | $40M | $39M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $26M | $52M | $84M | $76M | $57M |
| Other Non-Cash Items | $9M | $10M | -$11M | -$640K | -$43K |
| Operating Cash Flow | -$62M | -$45M | $3M | -$10M | -$38M |
| — Investing Activities — | |||||
| Capital Expenditures | -$38M | -$18M | -$8M | -$2M | -$26M |
| Acquisitions (Net) | -$188K | $0 | -$2M | $0 | $0 |
| Investment Purchases | -$188K | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $188K | $0 | -$5M | -$2M | $0 |
| Investing Cash Flow | -$38M | -$18M | -$15M | -$4M | -$26M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$2M | -$2M | $13M | $19M | $109M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$21M | -$23M | -$10M | -$28M | -$2M |
| Financing Cash Flow | -$23M | $45M | $4M | $16M | $106M |
| Net Change in Cash | -$123M | -$17M | -$9M | $2M | $41M |
| Cash End of Period | $50M | $32M | $24M | $26M | $67M |
| Free Cash Flow | -$100M | -$63M | -$11M | -$14M | -$64M |